In the ongoing quest to expand semaglutide’s clinical pedigree and cement the GLP-1's market position, Novo Nordisk is ...

Results from Novo Nordisk's STEP UP trial show that a high-dose formulation of Wegovy can significantly increase the weight ...

Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for ...

A high-dose form of Novo Nordisk’s obesity drug Wegovy ... the company said Thursday. Results from three late-stage trials showed treatment did not meet either the trial’s primary or secondary goals ...

Results from a study of a higher dose of Wegovy disappointed investors and European drug regulators said they were investigating cases of a rare eye condition after concerns it could be linked to ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 ... Services Secretary Xavier Becerra told reporters. “It lets us go after the biggest cost drivers in the prescription drug field for ...

Results from a study of a higher dose of Wegovy disappointed investors and European drug regulators said they were ...

Veru said Monday that its investigational drug helped preserve lean mass in patients taking the obesity treatment Wegovy, though some experts were skeptical that the topline results were adequate ...